Clinical Journal of the American Society of Nephrology

Article	Citations
Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis	256
Kidney Disease, Race, and GFR Estimation	163
Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19	151
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China	131
APOL1 Nephropathy: From Genetics to Clinical Applications	122
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)	121
Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications	107
Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2	89
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2	88
Social Determinants of Health and Race Disparities in Kidney Transplant	86
Drug-Induced Acute Kidney Injury	84
Classification of Uremic Toxins and Their Role in Kidney Failure	81
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia	80
The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019	78
Klotho in Clinical Nephrology	77
Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019	75
Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies	74
Skeletal Muscle Mitochondrial Dysfunction Is Present in Patients with CKD before Initiation of Maintenance Hemodialysis	71
Clinical Implications of an Acute Dip in eGFR after SGLT2 Inhibitor Initiation	68
Precision in GFR Reporting	65
Risk Factors for CKD Progression	65
Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation	65
Pathophysiology and Treatment of Enteric Hyperoxaluria	63
Utilization of Deep Learning for Subphenotype Identification in Sepsis-Associated Acute Kidney Injury	59
Fatigue in CKD	58

Long-Term Outcomes in IgA Nephropathy	57
Long-Term Immunosuppression Management	55
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury	55
Cuffless Blood Pressure Monitoring	54
Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19	53
Guidelines for Genetic Testing and Management of Alport Syndrome	52
Clinical Genetic Screening in Adult Patients with Kidney Disease	52
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1	50
Adverse Drug Reactions in Patients with CKD	49
Long-Term Infectious Complications of Kidney Transplantation	49
Major Bleeding and Risk of Death after Percutaneous Native Kidney Biopsies	47
COVID-19–Associated Mortality among Kidney Transplant Recipients and Candidates in the United States	47
Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis	47
Outcomes of COVID-19 in CKD Patients	47
Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy	46
Deep Learning Model for Real-Time Prediction of Intradialytic Hypotension	46
Nephrologist Follow-Up versus Usual Care after an Acute Kidney Injury Hospitalization (FUSION): A Randomized Controlled Trial	44
Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer	44
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD	44
Effect of Aerobic Exercise on Dialysis-Related Symptoms in Individuals Undergoing Maintenance Hemodialysis	44
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months	43
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health	42
COVID-19 in Peritoneal Dialysis Patients	41
The Pathophysiology of Sepsis-Associated AKI	40
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories	40
Dietary Potassium Intake and All-Cause Mortality in Adults Treated with Hemodialysis	39
Validation of a Core Patient-Reported Outcome Measure for Fatigue in Patients Receiving Hemodialysis	38
Intrauterine Growth Restriction and Risk of Diverse Forms of Kidney Disease during the First 50 Years of Life	38
COVID-19 in Patients with Kidney Disease	38
Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients	37
Mortality and Recovery Associated with Kidney Failure due to Acute Kidney Injury	37
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria	37
Recurrence of IgA Nephropathy after Kidney Transplantation in Adults	37
Dialysis Regret	36
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease	36
Management of Heart Failure Patient with CKD	36
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD	36
Environment-Wide Association Study of CKD	35
Antibody Response to mRNA-1273 SARS-CoV-2 Vaccine in Hemodialysis Patients with and without Prior COVID-19	35
Severity of COVID-19 after Vaccination among Hemodialysis Patients	35
A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility	34
Inherited Kidney Complement Diseases	34
Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes	34
Effect of Apabetalone on Cardiovascular Events in Diabetes, CKD, and Recent Acute Coronary Syndrome	34
Overweight and Obesity and Progression of ADPKD	33
Prevalence of Kidney Injury and Associations with Critical Illness and Death in Patients with COVID-19	33
Vaccination and COVID-19 Dynamics in Dialysis Patients	33
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks	33
Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease	33
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function	32

De Novo Malignancies after Kidney Transplantation	32
Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression	32
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy	32
Genetic Basis of Type IV Collagen Disorders of the Kidney	31
Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care	31
Donor Age, Cold Ischemia Time, and Delayed Graft Function	31
Risk of COVID-19 Disease, Dialysis Unit Attributes, and Infection Control Strategy among London In-Center Hemodialysis Patients	31
Recovery after Critical Illness and Acute Kidney Injury	31
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy	30
Association of Polypharmacy with Kidney Disease Progression in Adults with CKD	30
Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients	29
Recurrent Glomerular Disease after Kidney Transplantation	29
GWAS-Based Discoveries in IgA Nephropathy, Membranous Nephropathy, and Steroid-Sensitive Nephrotic Syndrome	29
Low Serum Bicarbonate and CKD Progression in Children	29
Ambulatory Treatments for RAAS Inhibitor–Related Hyperkalemia and the 1-Year Risk of Recurrence	29
The Continuum of Acid Stress	29
Preimplantation Genetic Testing for Monogenic Kidney Disease	29
Metabolic Alkalosis	29
Genome-Wide Association Studies of CKD and Related Traits	28
Association of Socioeconomic Status and Comorbidities with Racial Disparities during Kidney Transplant Evaluation	28
Neural Epidermal Growth Factor–Like 1 Protein–Positive Membranous Nephropathy in Chinese Patients	28
Inequity in Access to Transplantation in the United Kingdom	28
Acute Kidney Injury and Risk of CKD and Hypertension after Pediatric Cardiac Surgery	27
The Mobile Health Readiness of People Receiving In-Center Hemodialysis and Home Dialysis	27
COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression	27
Identification of Patients with CKD in Medical Databases	27
Managing Patients with Failing Kidney Allograft	27
Intradialytic Hypotension and Cardiac Arrhythmias in Patients Undergoing Maintenance Hemodialysis	26
Ertugliflozin and Slope of Chronic eGFR	26
Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy	26
Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19)	26
Long-Term Care of the Pediatric Kidney Transplant Recipient	26
Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline	25
Kidney-Protective Effects of SGLT2 Inhibitors	25
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum	25
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement	25
Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis	25
Association of Depressive Symptoms with Rapid Kidney Function Decline in Adults with Normal Kidney Function	25
Preliminary Assessment of Acute Kidney Injury in Critically Ill Children Associated with SARS-CoV-2 Infection	24
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease	24
Bone and Mineral Disease in Kidney Transplant Recipients	24
Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center	23
Video-Based Telemedicine for Kidney Disease Care	23
Pharmacist-Led Mobile Health Intervention and Transplant Medication Safety	23
Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD	23
Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease	23
SGLT2 Inhibitors in Diabetic Kidney Disease	23
Sex Disparity in Deceased-Donor Kidney Transplant Access by Cause of Kidney Disease	22
Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination	22
Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease	22
Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis	22
Chronic Allograft Injury	22
Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort	22
Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation	22
Reliability and Validity of the Patient Activation Measure in Kidney Disease: Results of Rasch Analysis	22
Acute Kidney Injury in Patients with Liver Disease	22
Assessing Global Kidney Nutrition Care	22
Safety and Efficacy of Belimumab in Patients with Lupus Nephritis	21
Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis	21
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease	21
Depression Screening Tools for Patients with Kidney Failure	21
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis	21
Evaluation of PROMIS Preference Scoring System (PROPr) in Patients Undergoing Hemodialysis or Kidney Transplant	21
Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide	20
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD	20
Postoperative Acute Kidney Injury	20
Development and Content Validity of a Patient-Reported Experience Measure for Home Dialysis	20
How COVID-19 Has Changed the Management of Glomerular Diseases	20
Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project	20
Provider Perception of Frailty Is Associated with Dialysis Decision Making in Patients with Advanced CKD	20
Outcomes of Patients on Maintenance Dialysis Hospitalized with COVID-19	20
Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis	20
Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States	20
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes	20
Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism	20
The Pathogenesis of Race and Ethnic Disparities	20
Expression of CD147 and Cyclophilin A in Kidneys of Patients with COVID-19	20
Metabolic Acidosis and CKD Progression	19
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy	19
Digenic Alport Syndrome	19

Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor–Associated Adverse Events	19
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood	19
External Validation of the International IgA Nephropathy Prediction Tool	19
Low-Flow Acute Kidney Injury	18
Metabolite Biomarkers of CKD Progression in Children	18
Associations between Deprivation, Geographic Location, and Access to Pediatric Kidney Care in the United Kingdom	18
Mass Disasters and Burnout in Nephrology Personnel	18
What Does Uromodulin Do?	18
Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD	18
Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease	18
The Kidney in Normal Aging	18
Soluble Klotho and Incident Hypertension	18
Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness	18
Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient	18
Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients	18
Electrolyte and Acid-Base Disorders Associated with Cancer Immunotherapy	17
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan	17
Kidney Disease Symptoms before and after Kidney Transplantation	17
Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis	17
Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD	17
Social Determinants of Kidney Health	17
Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression	17
Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature	17
The Seen and the Unseen: Race and Social Inequities Affecting Kidney Care	17
Use of Race in Kidney Research and Medicine	16
Waiting Time for Second Kidney Transplantation and Mortality	16
Variation in Peritoneal Dialysis Time on Therapy by Country	16
The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function	16
SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis	16
Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease	16
Symptom Burden before and after Dialysis Initiation in Older Patients	16
Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD	16
Urinary Cell mRNA Profiles Predictive of Human Kidney Allograft Status	16
Addressing Polypharmacy in Outpatient Dialysis Units	16
The Curious Story of Cerebral Salt Wasting	16
Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy	16
NephroTalk Multimodal Conservative Care Curriculum for Nephrology Fellows	16
Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kidney Replacement Therapy	16
Post-Transplant Cardiovascular Disease	16
Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease	15
Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease	15
Effect of the Refitted Race-Free eGFR Formula on the CKD Prevalence and Mortality in the Danish Population	15
In-Hospital and 1-Year Mortality Trends in a National Cohort of US Veterans with Acute Kidney Injury	15
Predictive Approaches for Acute Dialysis Requirement and Death in COVID-19	15
Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse	15
Collectin11 and Complement Activation in IgA Nephropathy	15
Digital Applications Targeting Medication Safety in Ambulatory High-Risk CKD Patients	15
Uric Acid and CKD Progression Matures with Lessons for CKD Risk Factor Discovery	15
Metabolites Associated with Coffee Consumption and Incident Chronic Kidney Disease	15
Transplant Clinician Opinions on Use of Race in the Estimation of Glomerular Filtration Rate	15
Strategies to Prevent Acute Kidney Injury after Pediatric Cardiac Surgery	15
Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019	15
Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019	15
Plasma Endothelin-1 and Risk of Death and Hospitalization in Patients Undergoing Maintenance Hemodialysis	14
Challenges with Providing Hospice Care for Patients Undergoing Long-Term Dialysis	14
Kidney Effects of Empagliflozin in People with Type 1 Diabetes	14
Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates	14
Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients	14
C3 Glomerulopathy and Related Disorders in Children	14
Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients	14
Performance of ChatGPT on Nephrology Test Questions	14
Food Insecurity and Kidney Disease	14
Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2– Recovered Dialysis Patients	14
The Importance of Kidney Medullary Tissue for the Accurate Diagnosis of BK Virus Allograft Nephropathy	14
Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese	14
Association of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease	14
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria	14
NAT8 Variants, N-Acetylated Amino Acids, and Progression of CKD	14
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis	14
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury	14
Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease–Associated Kidney Failure	14
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes	13
Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients	13
Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease	13
Racial Differences in Risk Factors for Kidney Stone Formation	13
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients	13
COVID-19 among Adults Receiving Home versus In-Center Dialysis	13
Donor Age, Donor-Recipient Size Mismatch, and Kidney Graft Survival	13
Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis	13
Kidney Disease Prevalence in Transgender Individuals	13
The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function	13
Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies	13
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance	13
Infection-Related Acute Care Events among Patients with Glomerular Disease	13
Targeting Sedentary Behavior in CKD	12
The Intensivist's Perspective of Shock, Volume Management, and Hemodynamic Monitoring	12
Lifesaving Care for Patients with Kidney Failure during the War in Ukraine 2022	12
Net Endogenous Acid Excretion and Kidney Allograft Outcomes	12
Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD	12
Transforming the Care of Patients with Diabetic Kidney Disease	12
Functional Reserve of the Kidney	12
Quality of Life before and after the Start of Dialysis in Older Patients	12
Can Novel Potassium Binders Liberate People with Chronic Kidney Disease from the Low-Potassium Diet?	12
Endothelin Receptor Antagonists for Kidney Protection	12
Vaccines and Disease Relapses in Children with Nephrotic Syndrome	12